Logo image of DCBO.CA

DOCEBO INC (DCBO.CA) Stock Fundamental Analysis

TSX:DCBO - Toronto Stock Exchange - CA25609L1058 - Common Stock - Currency: CAD

38.94  -0.85 (-2.14%)

Fundamental Rating

6

Taking everything into account, DCBO scores 6 out of 10 in our fundamental rating. DCBO was compared to 64 industry peers in the Software industry. DCBO is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. DCBO is not priced too expensively while it is growing strongly. Keep and eye on this one! With these ratings, DCBO could be worth investigating further for growth investing!.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

DCBO had positive earnings in the past year.
DCBO had a positive operating cash flow in the past year.
In multiple years DCBO reported negative net income over the last 5 years.
DCBO had a positive operating cash flow in 4 of the past 5 years.
DCBO.CA Yearly Net Income VS EBIT VS OCF VS FCFDCBO.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

The Return On Assets of DCBO (11.66%) is better than 87.50% of its industry peers.
The Return On Equity of DCBO (43.94%) is better than 92.19% of its industry peers.
DCBO's Return On Invested Capital of 21.50% is amongst the best of the industry. DCBO outperforms 93.75% of its industry peers.
Industry RankSector Rank
ROA 11.66%
ROE 43.94%
ROIC 21.5%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
DCBO.CA Yearly ROA, ROE, ROICDCBO.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 150

1.3 Margins

With an excellent Profit Margin value of 10.34%, DCBO belongs to the best of the industry, outperforming 82.81% of the companies in the same industry.
DCBO has a better Operating Margin (9.40%) than 76.56% of its industry peers.
DCBO has a better Gross Margin (80.94%) than 89.06% of its industry peers.
In the last couple of years the Gross Margin of DCBO has remained more or less at the same level.
Industry RankSector Rank
OM 9.4%
PM (TTM) 10.34%
GM 80.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
DCBO.CA Yearly Profit, Operating, Gross MarginsDCBO.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), DCBO is creating value.
Compared to 1 year ago, DCBO has about the same amount of shares outstanding.
The number of shares outstanding for DCBO has been increased compared to 5 years ago.
DCBO has a better debt/assets ratio than last year.
DCBO.CA Yearly Shares OutstandingDCBO.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DCBO.CA Yearly Total Debt VS Total AssetsDCBO.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

An Altman-Z score of 3.53 indicates that DCBO is not in any danger for bankruptcy at the moment.
DCBO has a better Altman-Z score (3.53) than 67.19% of its industry peers.
The Debt to FCF ratio of DCBO is 0.04, which is an excellent value as it means it would take DCBO, only 0.04 years of fcf income to pay off all of its debts.
DCBO's Debt to FCF ratio of 0.04 is amongst the best of the industry. DCBO outperforms 93.75% of its industry peers.
DCBO has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.00, DCBO belongs to the top of the industry, outperforming 85.94% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.04
Altman-Z 3.53
ROIC/WACC2.21
WACC9.73%
DCBO.CA Yearly LT Debt VS Equity VS FCFDCBO.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

DCBO has a Current Ratio of 1.15. This is a normal value and indicates that DCBO is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.15, DCBO perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
A Quick Ratio of 1.15 indicates that DCBO should not have too much problems paying its short term obligations.
DCBO has a Quick ratio (1.15) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.15
Quick Ratio 1.15
DCBO.CA Yearly Current Assets VS Current LiabilitesDCBO.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 336.36% over the past year.
The Revenue has grown by 16.79% in the past year. This is quite good.
DCBO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 39.25% yearly.
EPS 1Y (TTM)336.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.82%
Revenue 1Y (TTM)16.79%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%11.46%

3.2 Future

The Earnings Per Share is expected to grow by 27.76% on average over the next years. This is a very strong growth
Based on estimates for the next years, DCBO will show a very strong growth in Revenue. The Revenue will grow by 24.94% on average per year.
EPS Next Y39.51%
EPS Next 2Y29.84%
EPS Next 3Y21.71%
EPS Next 5Y27.76%
Revenue Next Year11.76%
Revenue Next 2Y12.58%
Revenue Next 3Y25.18%
Revenue Next 5Y24.94%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
DCBO.CA Yearly Revenue VS EstimatesDCBO.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M
DCBO.CA Yearly EPS VS EstimatesDCBO.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 29.50, the valuation of DCBO can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of DCBO indicates a somewhat cheap valuation: DCBO is cheaper than 79.69% of the companies listed in the same industry.
DCBO's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.30.
Based on the Price/Forward Earnings ratio of 19.60, the valuation of DCBO can be described as rather expensive.
DCBO's Price/Forward Earnings ratio is rather cheap when compared to the industry. DCBO is cheaper than 81.25% of the companies in the same industry.
DCBO's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.76.
Industry RankSector Rank
PE 29.5
Fwd PE 19.6
DCBO.CA Price Earnings VS Forward Price EarningsDCBO.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DCBO indicates a somewhat cheap valuation: DCBO is cheaper than 62.50% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, DCBO is valued a bit cheaper than 71.88% of the companies in the same industry.
Industry RankSector Rank
P/FCF 30.06
EV/EBITDA 30.18
DCBO.CA Per share dataDCBO.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

DCBO's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of DCBO may justify a higher PE ratio.
DCBO's earnings are expected to grow with 21.71% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.75
PEG (5Y)N/A
EPS Next 2Y29.84%
EPS Next 3Y21.71%

0

5. Dividend

5.1 Amount

DCBO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DOCEBO INC

TSX:DCBO (7/11/2025, 7:00:00 PM)

38.94

-0.85 (-2.14%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-09 2025-05-09/bmo
Earnings (Next)08-07 2025-08-07
Inst Owners36.86%
Inst Owner ChangeN/A
Ins Owners1.46%
Ins Owner ChangeN/A
Market Cap1.13B
Analysts78.67
Price Target40.09 (2.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)58.55%
Min EPS beat(2)26.05%
Max EPS beat(2)91.05%
EPS beat(4)3
Avg EPS beat(4)25.39%
Min EPS beat(4)-25.3%
Max EPS beat(4)91.05%
EPS beat(8)6
Avg EPS beat(8)-11.33%
EPS beat(12)10
Avg EPS beat(12)140.75%
EPS beat(16)12
Avg EPS beat(16)97.01%
Revenue beat(2)0
Avg Revenue beat(2)-1.06%
Min Revenue beat(2)-1.61%
Max Revenue beat(2)-0.51%
Revenue beat(4)1
Avg Revenue beat(4)-0.57%
Min Revenue beat(4)-1.61%
Max Revenue beat(4)0.37%
Revenue beat(8)1
Avg Revenue beat(8)-0.7%
Revenue beat(12)1
Avg Revenue beat(12)-1.11%
Revenue beat(16)3
Avg Revenue beat(16)-0.47%
PT rev (1m)-1.35%
PT rev (3m)-19.65%
EPS NQ rev (1m)-8.14%
EPS NQ rev (3m)-16.23%
EPS NY rev (1m)0%
EPS NY rev (3m)-6.77%
Revenue NQ rev (1m)-0.44%
Revenue NQ rev (3m)-0.39%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.31%
Valuation
Industry RankSector Rank
PE 29.5
Fwd PE 19.6
P/S 3.7
P/FCF 30.06
P/OCF 28.66
P/B 15.72
P/tB 22.36
EV/EBITDA 30.18
EPS(TTM)1.32
EY3.39%
EPS(NY)1.99
Fwd EY5.1%
FCF(TTM)1.3
FCFY3.33%
OCF(TTM)1.36
OCFY3.49%
SpS10.52
BVpS2.48
TBVpS1.74
PEG (NY)0.75
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 11.66%
ROE 43.94%
ROCE 36.68%
ROIC 21.5%
ROICexc N/A
ROICexgc N/A
OM 9.4%
PM (TTM) 10.34%
GM 80.94%
FCFM 12.31%
ROA(3y)6.1%
ROA(5y)2.04%
ROE(3y)18.51%
ROE(5y)8.92%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.38%
GM growth 5Y0.22%
F-Score8
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.04
Debt/EBITDA 0
Cap/Depr 39.83%
Cap/Sales 0.6%
Interest Coverage 250
Cash Conversion 118.32%
Profit Quality 119.04%
Current Ratio 1.15
Quick Ratio 1.15
Altman-Z 3.53
F-Score8
WACC9.73%
ROIC/WACC2.21
Cap/Depr(3y)34.45%
Cap/Depr(5y)55.59%
Cap/Sales(3y)0.56%
Cap/Sales(5y)1.02%
Profit Quality(3y)220.57%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)336.36%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%58.82%
EPS Next Y39.51%
EPS Next 2Y29.84%
EPS Next 3Y21.71%
EPS Next 5Y27.76%
Revenue 1Y (TTM)16.79%
Revenue growth 3Y27.67%
Revenue growth 5Y39.25%
Sales Q2Q%11.46%
Revenue Next Year11.76%
Revenue Next 2Y12.58%
Revenue Next 3Y25.18%
Revenue Next 5Y24.94%
EBIT growth 1Y347.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year120.45%
EBIT Next 3Y50.2%
EBIT Next 5Y32.1%
FCF growth 1Y2197.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1283.74%
OCF growth 3YN/A
OCF growth 5YN/A